Additionally, we found a correlation between leptin and “somatic anxiety” symptoms in MDD patients, and leptin was found to be a significant and indirect mediator between clinical status (MDD or FDR-MDD) and “somatic anxiety” symptoms, suggesting that leptin plays an indirect effect in somatic depressive symptoms in MDD. This evidence concerns the gene LEP and major depressive disorder.